Summary.-Seven days on a protein-free diet increases the susceptibility of rats to the action of DMN as a renal carcinogen. The dose response for the induction of kidney tumours by a single dose of dimethylnitrosamine (DMN) in these rats is reported. The first tumour was not found until 28 weeks after the dose. At 100 weeks the incidence ranged from 22.50/o at the lowest dose (20 mg/kg) to 97°h at the highest dose (60 mg/kg). The incidence in probits at any time between 50 and 100 weeks was linearly related to the log dose. Epithelial and mesenchymal tumours were produced in an approximate ratio of 2:1. The protein -free diet alters the rate of metabolism of DMN in the rat, and increases the alkylation of nucleic acids by this carcinogen in the kidney. Further treatment of the rat with benzo(a)pyrene can reverse, to some extent, the change in metabolism, but does not reverse the change in alkylation. It is shown that the change in kidney-tumour incidence produced by the change in diet, and by the treatment with benzo(a)pyrene, corresponds to the changes these treatments produce in the alkylation of kidney DNA by the carcinogen.
THE DISCOVERY that only a single dose of dimethylnitrosamine (DMN) is needed to induce kidney tumours in the rat (Magee & Barnes, 1962) was soon followed by the report that some other N-nitroso compounds are equally effective (Druckrey et al., 1964) . The ability to produce cancer with a single dose of carcinogen opened the way to a number of previously impossible experiments. However, each of these carcinogenic nitroso compounds had some disadvantage which reduced its usefulness as an experimental tool. Some produced tumours in many organs so that it was difficult to study one single type of tumour, and others, which were specific for just one organ, required a very large dose to induce even a low incidence of tumours. For example a median lethal dose of DMN produced only a 20%0 incidence of kidney tumours. This low incidence of tumours, and the many severe changes in the metabolism of the animal produced by the near lethal dose, limited the usefulness of this means of inducing cancer. However, kidney tumours can be induced in every rat if the animals are given a protein-free diet for 7 days before, and 5 days after, the single dose of DMN (Swann & McLean, 1968; Hard & Butler, 1970; McLean & Magee, 1970) . The diet influences the effectiveness of the nitrosamine as a renal carcinogen in 2 ways: it allows the rat to tolerate a much larger dose (the median lethal dose is almost doubled) (McLean & Verschuuren, 1969) ; and it alters the pharmacokinetics of the nitrosamine so that the proportion of any dose activated to the proximal carcinogen in the kidney is greatly increased (Swann & McLean, 1971) . These 2 effects complement each other so that a dose of DMN well below the LD50 will induce kidney tumours in every one of the rats (Swann & McLean, 1968; Hard & Butler, 1970; McLean & Magee, 1970) .
The histogenesis and histological development of these kidney tumours has been studied (Hard & Butler, 1970 , 1971 and an attempt has been made to identify the biochemical events crucial to their development, by studying the effect on them of inhibitors of protein and nucleic acid synthesis (Stewart & Magee, 1973) . Because the results of this study could not be compared with a dose-response curve it was unsatisfactory. It could not show wbether a large or a small change in dose of carcinogen was needed to produce the same change in incidence as produced by the drug treatment. Furthermore, a doseresponse curve would have indicated the optimum number of animals, and the most appropriate dose of carcinogen.
In this paper the dose-response for the induction of kidney tumours by DMN in these protein-deprived rats is described, and it is shown that the effect of the change of diet, and of pretreatment with benzo(a)pyrene, on the incidence of kidney tumours produced by DMN corresponds to the effect of these treatments on the alkylation of kidney DNA by the nitrosamine.
MATERIALS AND METHODS
Animals.-Wistar-derived male rats of CFN stock (5-6 wNeeks old; 130-140 g) were bought from Carworth Farms, New City, N.Y., U.S.A. After 5-7 days' acclimatization, during which they were fed Purina Chow (Ralston Purina Corp., St Louis, Mo., U.S.A.), they were changed to a semi-synthetic diet containing no protein (McLean & McLean, 1966) . Those rats to be treated were weighed and given an i.p. injection of a solution of DMN in 015M NaCl (0.5 ml/100 g body wt) on the morning of the 7th day on the diet. (Controls were injected with a similar volume of 0-15M NaCl at the same time.) After a further 5 days on this diet (i.e. a total of 12 days) the rats were returned to the normal diet of Purina Chow. While they were receiving the protein-deficient diet the rats were kept in cages with gridded bottoms so that they were unable to eat faeces or bedding.
Outbred Osborne Mendel rats and inbred Buffalo rats were supplied by the Laboratory Aids Branch, National Institutes of Health, Bethesda, Md 20014, U.S.A.
Determination of the effect of a protein-free diet on the LD50 of DMN.-The LD5Os were determined (Weil, 1952) in rats on a normal diet (Purina Chow) or on protein-free diet. Twenty-four CFN male rats, 24 Osborne Mendel male rats, and 24 male Buffalo rats (in all cases 140-170 g) were acclimatized, kept on a protein-free diet, and treated with DMN as detailed above. The LD50 in these rats was compared with that in a similar number of rats fed only Purina Chow.
The influence of the protein-deficient diet or pretreatment with benzo(a)pyrene on the metabolismof DMN by liver and kidney slices in vitro, and on the methylation of liver and kidney DNA in vivo by a single dose of [14C]DMN.-Previously described methods (Swann & McLean, 1971) were used to assess the influence of diet and pretreatment with benzo(a)pyrene on the extent of methylation of liver and kidney DNA produced in vivo by a dose of DMN, and upon the ability of liver and kidney slices to metabolize DMN in vitro. In both studies CFN rats were fed either a normal diet, or a protein-free diet for 7 days. After 4 days, half the rats on each diet were given a single i.p. dose of benzo(a)pyrene (20 mg/kg body wt as an 8mg/ml solution in maize oil). On the 7th day 5 animals from each group were given a single i.p. dose of [14C] DMN (40 mg/ kg body wt). The animals on the normal diet were killed 8 h, and those on the protein-free diet 15 h, after the dose, and the amount of N-7-methylguanine in the DNA of the pooled kidneys measured. The interval between dose and death was longer (15 h) in the animals on the protein-free diet because these animals metabolize DMN more slowly. The remaining animals were also killed and the ability of slices of their livers and kidneys to metabolize DMN in vitro was measured.
Determination of the incidence of kidney tumours produced by various amounts of DMN, and the effect on that incidence of pretreatment with benzo(a)pyrene. The CFN rats were acclimatized, changed to a protein-free diet and treated with DMN (20, 30, 40, 50 or 60 mg/kg body wt) as detailed above. The number of rats in each group is given in Table II . There was one untreated control group of rats on a normal diet (Purina Chow), and another on the protein-deficient diet. Both groups were injected with O15M NaCl (0-5 ml/100 g body wt).
The effect of benzo(a)pyrene on DMNinduced kidney-tumour incidence in the protein-deprived rat was studied by giving one dose (20 
RESUTLTS
In the (FN rats the LD50, which had been 35-7 mg/kg body wt (log standard deviation 0o0685, i.e. between 30 4 and 41'8 mg/kg) in rats fed Purina Chow, was increased to 60-7 mg/kg body wt (log s.d. 0-0290, i.e. between 56-7 and 65 mg/kg) by 7 days' pre-treatment with a proteinfree diet. The protein-deficient diet also protected Osborne Mendel rats, increasing the LD50 from 316 mg/kg (29.4-34) on the normal diet, to 46 mg/kg (41.3-51'8), but did not protect Buffalo rats, where the LD50 which was 51-6 mg/kg (47.3-55.9) on the normal diet, actually decreased to 45-2 mg/kg (43.2-47'3) when the rats were pretreated with the protein-free diet.
A single dose of 40 mg DMN/kg body wt produced 0 7 mmol N-7-methylguanine/ mol guanine in the DNA of the pooled kidneys of 5 CFN rats on a normal diet; 1*2 mnmol in the kidneys of 5 rats on a protein-free diet; and 1-2 mmol in the kidneys of 5 rats pre-treated with benzo-(a)pyrene while on a protein-free diet. In this experiment the standard deviation of these numbers was not measured, but in our experience the variation from rat to rat was small. In another experiment the alkylation of liver DNA in 22 separate rats given DMN had an s.d. of 12%. The variation in the alkylation of kidney DNA has not been studied so thoroughly but appears to be similar. Liver slices in vitro were able to metabolize DMN to CO2 at the following rates (nmol C02 produced/g tissue/h): liver slices from CFN rats on a normal diet, 361 + 29; liver slices from CFN rats after (O) 32 (53) 10 (40) 34 (62) 37 (82) 42 (76) 32 (80) 20 (50) 6 (24) 11 (44) The time of appearance of kidney tumours in the rats treated with DMN while on the protein-free diet (Groups 3-7) is shown in Fig. 1 . These points represent the time the rat died and was subsequently found to have a kidney tumour, or the time at which the rat was killed after a kidney tumour had been detected by palpation. If the tumour incidence in Fig. 1 at any one time between 50 and 100 weeks is plotted as incidence vs dose, a sigmoid curve is obtained (e.g. Fig. 2(a) , which shows the results at 60 weeks). These curves can be converted into straight lines by replotting them as probit-of-incidence against log dose (for example Fig. 2(b) ), a maximum-likelihood regression analysis can be carried out, and fiducial lines calculated (Finney, 1971) . Regression analysis was carried out on the results in Fig. I at each 10-week interval between 50 and 100 weeks. The time of appearance of kidney tumours in the rats treated with DMN and with benzo(a)pyrene is given in Fig. 1(a) , and in those given DMN on a normal diet in Fig. 1(b) (Table III) . Seventy-two of the rats given DMN had lung tumours, either adduomas or adenocarcinomas. No lung tumours were found in the untreated rats.
It is reasonable to ascribe the kidney and lung tumours to the nitrosamine treatment, though some other types of tumours were found in both treated and untreated animals. The majority of these were fibrosarcomas at several sites, mostly just below the skin. Some apparently neoplastic lesions were also found in the livers; most appeared to be hepatomas, with a few angiomas and cholangiomas.
Although the incidence of these lesions was higher in the nitrosamine-treated (50) 8 (21) 11 (29) 23 (77) 3 (10) 4 (13) 9 (69) 4 (31) 0 24 (77) 2 (6) 5 (16) Abbreviations: DMN, dimethylnitrosamine; BP, benzo(a)pyrene. * 20 mg benzo(a)pyrene/kg.
animals, it is not certain that they were caused by the nitrosamine treatment: the incidence of the lesions was not doserelated, and it is generally accepted that a single dose of DMN does not induce liver tumours (Craddock, 1976) .
DISCUSSION
Before the strain of rats for the main experiments was chosen the effect of the protein-free diet on the toxicity of DMN was measured in 3 strains. It was found that 7 days on the diet reduced the susceptibility of CFN and Osborne Mendel rats to the toxic effects of DMN, but did not protect the Buffalo rat. Because of this CFN rats were chosen for all the subsequent experiments.
The Buffalo is not the only strain in which the protein-free diet has no effect on the toxicity of the nitrosamine (Waynforth et al., 1977) . The most striking effect of DMN-poisoning is liver damage, probably induced by the reactive metabolites of the nitrosamine. The protein-free diet decreases the ability of the rat to metabolize DMN. The liver is affected to a greater extent than other organs, and it is believed that this may be the basis for the protection (Swann & (Barnes & Magee, 1954) . A counterpart to the decrease in the capability of the liver to metabolize DMN is an increase in the amount metabolized in other organs (Swann & McLean, 1.971) which increases the damage in these organs. It is possible that in some strains of rat any protective effect of diet is counterbalanced by an increase in the contribution of pathological changes in the Itings and other oro,ans to the death of the animals.
The time of appearance of kidney tumours in rats given a single dose of IDMN is given in Fig. 1 . In most cases this was the time that the tumours were of siifficient size to be detected by palpation, or to kill the animal. The first tumour was found 28 weeks after administration of the carcinogen. It is particularly interesting that some tumours, mostly small adenomas, were not found until the surviving rats were killed 104 weeks after the carcinogen had been administered, and microscopic examination of the kidneys was carried out. It is difficult to assess the significance of these lesions, but the steady increase in the number of clinically significant tumours in the groups given the lower doses (Fig. 1) by the dose, the average time between the dose and appearance of each tumour was much greater in the rats given the lower doses than in those given the higher doses (Fig. 1) . A relationship between dose and the time of appearance of tumours has also been found when brain tumours were induced in the offspring of rats given a single dose of ethylnitrosourea (Druckrey et al., 1970; Swenberg et al., 1972) and in many experiments where carcinogens were given continuously (Druckrey, 1967) . There was no significant difference between the time of appearance of the mesenchymal and epithelial tumours.
It is not known why the first tumour takes so long to appear, but it is probably not simply the time needed for the tumour to grow to a sufficient size to be detected.
Microscopic study (liard & Butler, 1971) (Hard & Borland, 1977; Hard, 1978) . Other experiments in tissue culture have also shown that time is essential for the full development of malignancy (Laerum & Raiewsky, 1975; Barrett & Ts'o, 1978; Roscoe & Claisse, 1978) and are in general accord with conclusions drawn from pathology (Foulds, 1969) and mathematical analysis of the relationship between age and the incidence of cancer in man (Doll, 1971; Peto, 1977) that transformation of tissue from the normal state to cancer is a multistage process. The increase in the average time for the development of tumours (Fig. 1) as the dose is lowered suggests the interesting possibility that the initiation of cancer is not just a switch from normality to the first premalignant stage, but a process which propels the cell towards the malignant state, and that the time needed to achieve full malignancy depends upon the intensity of that initial propulsion, i.e. the nature and dose of carcinogen.
Previous studies (Swann & McLean, 1971) had shown that pre-treatment with the protein-free diet altered the pharmacokinetics of the nitrosamine so that a greater proportion of any dose was activated to the proximal carcinogen in the kidney. When designing these experiments we hoped to discover whether the increase in tumour incidence was entirely the result of the change in the pharmacokinetics or whether the diet also produced a change in the inherent susceptibility of the kidney. To decide this it was necessary to find the difference in incidence of tumours when DMN is given to rats on a protein-free diet, and on a normal diet; and to compare this with the difference predicted from knowledge of the pharmacokinetics. If there was no difference between the observed and predicted differences, there must be no change in the inherent susceptibility of the kidney to the carcinogen.
The influence of changes in diet, or other treatments, on the metabolism of DMN in various organs can be estimated by measuring the metabolism by tissue slices in vitro, or the alkylation of DNA of different organs produced by a dose of DMN in vivo (Swann & McLean, 1971) . The protein-deficient diet increases the amount of nitrosamine metabolized in the kidney because metabolism is inhibited more in the liver than in the kidney (Swann & McLean, 1971) . In these CFN rats the metabolism of DMN by liver slices was reduced to 26% of normal by the protein-free diet, whilst the metabolism by kidney slices was reduced to 56% of normal. The rat excretes only a small amount of DMN, so the selective inhibition of metabolism in the liver increases the proportion of the dose metabolized in the kidney and increases the alkylation of kidney DNA. The amount of alkylation of kidney DNA of rats on the protein-free diet was 1 * 7 times greater than in the kidneys of rats on a normal diet. If the tumour incidence was related to the amount of alkylation one would expect 23 mg DMN/kg in rats on a protein-free diet to produce the same incidence of tumours as 40 mg/kg on a normal diet. The incidence of tumours at various times in rats given 40 mg DMN/kg on a normal diet ( Fig. 1(b) ) can be expressed as probits and substituted into the equations describing the dose response in the proteindeprived rats (Results Section). It is then estimated that rats on a protein-free diet require only 24-4 mg DMN/kg to produce the same incidence. (The individual estimates were 23 4, 25-6, 23-8, 25 .0, and 24-0 mg/kg when the comparison was made at 50, 60, 70, 80, 90, and 100 weeks.) Since the relative effectiveness of the carcinogen predicted from the amount of alkylation of kidney DNA produced by DMN in rats on the 2 dietary regimes is so similar to the relative effectiveness observed, it seems that the protein-free diet produces little change in the inherent susceptibility of the kidney to this carcinogen.
Benzo(a)pyrene pre-treatment partially reverses the effect of the protein-free diet on the rate of metabolism of DMN by liver slices, increasing it from 26% to 78 o of normal. One might expect therefore that pre-treatment with benzo(a)pyrene would increase the toxicity of the nitrosamine. Although a formal LD50 was not carried out, this prediction accords with the observation that whereas 24% of the rats on the protein-free diet were killed by 40 mg DMN/kg, 550o were killed when the rats were pre-treated with benzo(a)-pyrene (Table I) .
The metabolic studies suggested that pre-treatment with benzo(a)pyrene should have less effect on the incidence of kidney tumours than it had on toxicity. Treatment with benzo(a)pyrene restores the activity of the liver slices of the proteindeprived rat to 78% of normal, but increases the activity of kidney slices to 115% of normal. Thus although the overall rate of metabolism had been largely restored, the balance is towards metabolism by the kidney. The alkylation of kidney DNA by 40 mg DMN/kg was the same in the benzo(a)pyrene-treated, protein-deprived rats, as in those on the protein-free diet alone (0.12 Hmol N-7-methylguanine/mol guanine). Thus if tumour incidence were related to the amount of alkylation one would not expect benzo(a)-pyrene treatment to affect the kidneytumour incidence produced by DMN in the protein-deprived rat. The results ( Fig. 1(a) ) are consistent with that prediction. The incidence of tumours at various times in the rats given 40 mg DMN after treatment with benzo(a)pyrene can be converted to probits and substituted in the equations given in the results. It is then found that the apparent median tumorigenic effect is that expected from 37-1 mg DMN in the untreated rat (the individual values are 35 7, 39.4, 39.7, 39.9, 36-8 and 34 0 mg/kg at 50, 60, 70, 80, 90 and 100 weeks).
These results are preliminary, and further work is needed on the relationship between the metabolism of DMN, the alkylation of nucleic acids, and the catcinogenic activity of the compound. These results suggest, however, that when a. given treatment changes the incidence of tumours, it should be possible to assess how much that change is due to a change in the metabolism of the introsamine and how much it is due to a change in the inherent susceptibility of the tissue.
